Who Paid My Doc
Flexitime Mono Phase 1 X (2 X 50 ML)
Device Elw
PDI J014500348110
General payments
$2,029
Research payments
$0
Through program year 2025, $2,029 in general payments and $0 in research payments were reported against Flexitime Mono Phase 1 X (2 X 50 ML) (Elw).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $489 | 5 |
| 2024 | General | $1,387 | 4 |
| 2023 | General | $114 | 7 |
| 2022 | General | $38 | 2 |
Breakdown
Each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2025 where a state was reported.
Records
18 generalEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.